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Abstract
Background: The number of patients suffering post-stroke seizure after ischemic stroke (PSSi) is quite considerable,
especially because ischemic stroke is more prevalent than hemorrhage in the general population. This study aimed
to determine the predicting factors for seizure recurrence in ischemic stroke survivors and develop a clinical scoring
system for the prediction of risks for seizure recurrence after the first PSSi.
Methods: We reviewed 3792 ischemic stroke patients from the Ewha Stroke Registry. A total of 124 (3.3 %) patients
who experienced PSSi were recruited (mean follow-up for 44.4 months). Medical records concerning the etiology,
functional disability, seizure onset latency from stroke, type of seizure, electroencephalography (EEG), and
neuroimaging findings were statistically analyzed to derive a seizure recurrence risk scoring system.
Results: Seizures recurred in 35.4 % (17/48) of early PSSi patients (≤1 week since stroke onset) and 48.7 % (37/76)
of late PSSi (>1 week) patients. Atrial fibrillation, large sized, and cortical stroke lesion were more common in late
onset PSSi compared to those in early onset PSSi (p < 0.05). Seizure recurrence tended to be more prevalent in early
PSSi patients with male gender, atrial fibrillation or cortical stroke lesion, severe functional disability, and partial
seizures. Seizure recurrence in late PSSi group was more common in patients of young age (≤65 years old), male
gender, large lesion size, and partial seizure type. The validity of seizure recurrence risk score in the early PSSi group
was better when evaluating based on gender, atrial fibrillation, cortical lesion, functional disability, and partial
seizure type, with sensitivity of 70.6 % and specificity of 71.0 %.
Conclusions: Our study characterized the high risk group for seizure recurrence in patients with the first PSSi. PSSi
patients with high risk score of seizure recurrence had a greater chance of developing epilepsy later. Therefore,
they should be considered for further treatment such as antiepileptic drug medication in clinical practice.
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Background
Stroke, one of the major causes of epilepsy, accounts for
up to 11 % of epilepsy patients in western countries [1].
American Stroke Association has recently reported that
about one in six (15.3 %) stroke survivors experiences
seizures within about 3.4 years after suffering brain at-
tack [2]. Disabling large cortical stroke lesions and
hemorrhagic strokes are known to be associated with
frequent acute symptomatic seizures [2–12]. In succes-
sion, stroke leads to a 23-fold increase in remote sei-
zures and a 17-fold increase in epilepsy incidence rate
after the acute phase [13]. However, these epidemiologic
analyses have not provided clinical scales for the predic-
tion of seizure recurrence nor treatment guidelines such
as when to start anti-epileptic drug (AED) for those pa-
tients with high risk of seizure recurrence.
In fact, AEDs have been often prescribed for remote
seizures due to higher likelihood of subsequent unpro-
voked events [11, 14]. However, AED prophylaxis is not
generally considered to prevent development of future
epilepsy regardless of etiology. The most debating point
is whether AED is needed after the first acute symptom-
atic seizure. Up to date, there is no consensus on treat-
ment option for patients with post-stroke seizure after
ischemic stroke (PSSi) except individualization depend-
ing on each clinician's own criteria [15, 16], although
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there are some clinical evidence and guidelines on AED
management for post-hemorrhagic stroke seizure (PSSh)
patients [17, 18]. This is probably caused by the fact that
seizures are less frequent complication after infarction (2–
13.5 %) than hemorrhages (4.3–24 %) [2, 3, 5, 6, 11, 12].
However, the number of PSSi patients is pretty high be-
cause cerebral ischemia is much more prevalent than
hemorrhage, especially in Korean population (76.1 % vs.
23.9 % respectively [19]), with increasingly ageing
populations.
AED treatment has been generally recommended
for PSSi patients after the second seizure event, but
not for the first PSSi, except when status epilepticus
occurs as seizure onset [20]. This recommendation is
based on the investigated virtue that AEDs might re-
duce the occurrence of second seizure, although
AEDs have no effect on the pathogenesis of disease
or its late prognosis [21, 22]. The location of stroke le-
sions has been reported as an important clinical factor en-
during predisposition to generate further seizures. In
addition, several previous studies have verified that early
PSSi is an independent risk factor for the development of
late and recurrent seizures [9, 13].
Early seizure control is important because uncon-
trolled repetitive seizures may threaten patients not
only through potential physical injuries, but also
through deleterious effects on the brain with stroke
lesion and degenerative changes considering the fact
that patients are mainly the elderly. It is also plausible
that recurrent peri-infarct depolarization might be
harmful to already vulnerable tissues because the add-
itional metabolic stress could cause further neuronal
injuries [23, 24]. Although whether seizures are dir-
ectly connected to worse stroke outcome remains
controversial, seizures after stroke are known to be
related to increased resource utilization and length of
hospital stay as well as decreased survival at 30-day
and 1-year time points [12, 25, 26].
The present study aimed to better define the clinical
factors for predicting high risk of seizure recurrence
after the first PSSi. Out study placed a special emphasis
on the seizure recurrence predicting factors among is-
chemic stroke survivors, hopefully to develop practical
AED treatment guideline. The proposed clinical scale for
predicting seizure recurrence could provide clinicians
with practical implications on ischemic stroke survivor
management, such as identifying the population that
might benefit from immediate AED intervention.
Methods
Patients
Among a total of 3792 consecutive patients admitted to
Ewha Womans University Hospital between 2001 and
2012 due to cerebral infarction, 124 PSSi patients were
included in this study. Data were obtained from medical
records of their routine care for stroke and seizure at ad-
mission and outpatient department visits. The study
endpoint of each individual was the last outpatient visit
or seizure recurrence. Mean follow-up duration was
44.4 months from relevant ischemic stroke insult and
29.9 months from PSSi onset.
Definitions
Acute stroke was defined as occurrence of acute neuro-
logical symptom of presumed vascular origin lasting
24 h or longer. It was confirmed by radiologic findings.
Transient ischemic attack (TIA) was excluded. Primary
hemorrhagic stroke and patients who were previously di-
agnosed with epilepsy or had probable epileptogenic le-
sions such as cerebral hemorrhage, traumatic brain
injury, brain surgery, cortical dysplasia, brain tumor, and
cerebral vascular malformation were also excluded.
Radiologic evidence of clinically silent old lacunar infarc-
tions, periventricular leukoaraiosis, and secondary
hemorrhagic transformation of ischemia were not con-
sidered as exclusion criteria. In case of recurrent stroke,
clinically significant and the most recent accident before
the first seizure, regardless of lesion size and location,
was considered as PSSi relevant stroke.
Seizure was diagnosed clinically, and distinguished
as being partial or generalized, according to the 2010
International League Against Epilepsy (ILAE) criteria
[27, 28]. Consequently, non-convulsive electroenceph-
alographic (EEG) seizure was ruled out. Simple loss
of consciousness or short-lasting episodes of mental
confusion was not considered as sufficient for epilep-
tic seizure diagnosis. Status epilepticus was defined as
one continuous and unremitting seizure lasting for
more than 5 min or recurrent seizures without restor-
ation of consciousness for greater than 5 min [29].
Criteria for early and late PSSi were within 7 days or
later from stroke onset [20, 30]. No distinction was
made between acute symptomatic seizures and early
PSSi. The recurred second seizure event was unpro-
voked and separated from the first one by more than
24 h according to the epilepsy definition [28].
Clinical variables and indicators for seizure outcomes
To diagnose and determine the pathogenesis of stroke,
all patients were investigated in a standardized fashion
including neuroimaging modality (computed tomog-
raphy [CT] or magnetic resonance imaging [MRI] with/
without angiography). Duplex ultrasound and trans-
esophageal or transthoracic echocardiography (TEE/
TTE) were performed when necessary for further etio-
logical classification (Trials of Org 10172 in Acute
Stroke Treatment [TOAST] classification) [31].
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Image was obtained within 24 h of PSSi relevant
stroke onset. Infarct size was categorized as: small
(≤15 × 15 mm and ≤ 5 slices), moderate (≤15 × 15 mm
and > 5 slices or > 50 × 50 mm and ≤ 5 slices), and large
(>50 × 50 mm and > 5 slices). Image follow-up was per-
formed to rule out new epileptogenic lesions in the late
PSSi group and patients with seizure recurrence. Func-
tional disability was evaluated at discharge after stroke
care based on the modified Rankin score (mRS) catego-
rized as mild (mRS ≤ 1), moderate (2 ≤mRS ≤ 3), or se-
vere (mRS ≥ 4). Standard EEG of 20–30 min duration
was performed within 24–72 h of PSSi onset and coded
as normal, generalized slow, regional slow, or focal epi-
leptiform discharge. Analysis was performed to deter-
mine whether EEG findings were correlated with
relevant stroke lesion.
Seizure recurrence risk scoring models
After compiling results from previous studies and our
own results, we defined the following 10 clinical seiz-
ure recurrence predictors after the first PSSi: seizure
onset age under 65 years old [3, 4, 12], male gender
[10], atrial fibrillation, lesion size [9, 10, 12], cortex
involvement [4, 5, 8–10, 12, 32], hemorrhagic trans-
formation [5, 11, 32], functional disability conse-
quence of stroke [3, 4, 7–9, 32, 33], status epilepticus
[34], stroke lesion correlative EEG findings [33], and
partial seizure. We derived and validated several scor-
ing models based on the combination of these factors
to predict seizure recurrence in early and late PSSi
groups, respectively. Another two models from the
Post-Stroke Epilepsy Risk Scale (PoSERS) studies [32]
and the medical research council (MRC) Multicenter
trial for Early Epilepsy and Single Seizures (MESS)
[33] were also applied to our patients and compared
to our own scales.
Statistical analysis
All statistical data analyses were performed using SPSS
ver. 21.0 (SPSS Inc., Chicago, IL, USA) and MedCalc
programs (MedCalc Software Inc., Ostend, Belgium).
Chi-square, Fisher’s exact test, and linear by linear asso-
ciation were used to compare categorical variables. Inde-
pendent t-test was used for continuous variables to
make univariable comparisons of clinical characteristics.
Multivariable analysis was conducted using logistic re-
gression model. Two-sided p-value of less than 0.05 was
considered as statistically significant. Associations were
evaluated by odd ratios (OR) with 95 % confidence inter-
vals (CI). Receiver operating characteristic (ROC) curve
analysis was conducted for performance measure of total
scale and different subscales after item selection.
Results
Patient characteristics
A total of 124 (3.3 %) PSSi occurred in 3792 ischemic
stroke patients. There were 69 males and 55 females
(1.3:1). The median age of patients with first seizure
after ischemic stroke was 68 years old. Of the 124 pa-
tients, 48 (38.7 %) had early seizures. The remaining 76
(61.3 %) had late seizures. Among the 48 early PSSi pa-
tients, 77.1 % (37/48) of seizures occurred concurrently
within 24 h after stroke onset (Fig. 1). Mean latency be-
tween stroke and late PSSi was 22.4 months (range,
9 days to more than 10 years), with peak time point of
6–12 months after stroke insult. Mean follow-up dur-
ation was 44.4 months after stroke and 29.9 months
after the first seizure.
Early vs. Late post-ischemic stroke seizures
The clinical characteristics of patients in the early and
late PSSi groups are summarized in Table 1. No signifi-
cant difference in seizure onset age, sex, or history of
diabetes mellitus and hypertension was found between
Fig. 1 Latency of post-ischemic stroke seizure occurrence since
cerebral infarction. a Distribution of seizure onset latency, and b
cumulative number of patients. In the early onset group (grey),
the first seizure occurred concurrently with stroke (within 24 h)
in 77.1 % (37/48) of patients. In the late onset group (black), the
latency exhibited a wide variation with a mean of 22.4 months.
The peak period was at 6 months to 1 year after stroke
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the two groups. However, atrial fibrillation was more
prevalent in the late seizure group compared to that in
the early PSSi group (36.8 % vs. 16.7 %, p = 0.016). The
most common stroke etiology was large artery athero-
sclerosis (LAA) in both groups (54.2 % vs. 56.6 %). The
second common etiology was small vessel occlusion
(SVO) (18.8 %) in the early seizure group and cardioem-
bolism (CE) (28.9 %) in the late seizure group. This was
different from the statistics of Korean Clinical Research
Center for Stroke which reported the etiology
Table 1 Comparison of clinical characteristics related to early and late onset post-ischemic stroke seizures
Clinical characteristics Total Early onset Late onset p-value OR (95 % CI)
(N = 124) (N = 48) (N = 76)
Age (years) Median 68.0 68.0 69.0 0.670
Interquartile range 57.0–75.0 55.5–75.8 59.0–74.5
Gender Male 69 29 (60.4 %) 40 (52.6 %)
Female 55 19 (39.6 %) 36 (47.4 %) 0.395 1.374 (0.660–2.859)
Diabetes mellitus 44 20 (41.7 %) 24 (31.6 %) 0.253 0.646 (0.305–1.369)
Hypertension 89 33 (68.8 %) 56 (73.7 %) 0.552 1.273 (0.574–2.820)
Atrial fibrillation 36 8 (16.7 %) 28 (36.8 %) 0.016* 2.917 (1.197–7.108)
TOAST classification LAA 69 26 (54.2 %) 43 (56.6 %)
CE 26 4 (10.4 %) 22 (28.9 %)
SVO 16 9 (18.8 %) 7 (9.2 %)
Other determined 2 1 (2.1 %) 1 (1.3 %)
Undetermined 10 7 (14.6 %) 3 (3.9 %)
Lesion size Small 10 7 (14.6 %) 3 (3.9 %)
Moderate 31 17 (35.4 %) 14 (18.4 %)
Large 83 24 (50.0 %) 59 (77.6 %) 0.001**
Cortical involvement 106 35 (72.9 %) 71 (93.4 %) 0.002** 5.274 (1.742–15.972)
Hemorrhagic transformation 28 8 (16.7 %) 20 (26.3 %) 0.211 1.786 (0.715–4.458)
Vascular territory ACA 9 3 (6.3 %) 6 (7.9 %)
MCA 76 23 (47.9 %) 53 (69.7 %)
ICA 13 6 (12.5 %) 7 (9.2 %)
Lacune 10 7 (14.6 %) 3 (3.9 %)
Watershed 6 4 (8.3 %) 2 (2.6 %)
PCA 7 3 (6.3 %) 4 (5.3 %)
Venous 2 1 (2.1 %) 1 (1.3 %)
Brainstem 1 1 (2.1 %) 0
Functional disability Mild 28 16 (33.3 %) 12 (15.8 %)
Moderate 35 6 (12.5 %) 29 (38.2 %)
Severe 61 26 (54.2 %) 35 (46.1 %) 0.527
Status epilepticus 33 13 (27.1 %) 20 (26.3 %) 0.925 0.962 (0.425–2.175)
EEG findings Normal 20 9 (18.8 %) 11 (14.5 %)
(n = 116) Generalized slow 17 9 (18.8 %) 8 (10.5 %)
Regional slow 59 19 (39.6 %) 40 (52.6 %)
Epileptiform discharge 20 8 (16.7 %) 12 (15.8 %) 0.136a 1.825 (0.824–4.040)
Clinical seizure type Generalized 68 23 (47.9 %) 45 (59.2 %)
Partial 56 25 (52.1 %) 31 (40.8 %) 0.218 0.634 (0.306–1.312)
Seizure recurrence 54 17 (35.4 %) 37 (48.7 %) 0.147 1.730 (0.823–3.637)
OR odds ratio, CI confidence interval, TOAST Trials of Org 10172 in Acute Stroke Treatment, LAA Large artery atherosclerosis, CE Cardioembolism, SVO Small vessel
occlusion, ACA anterior cerebral artery, MCA middle cerebral artery, ICA internal cerebral artery, PCA posterior cerebral artery, EEG electroencephalography
Statistical significance with p < 0.05* and p < 0.01**
a Variables were substituted whether EEG findings were correlated with the relevant stroke lesion to evaluate the p-value
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distribution was 36.1 % for LAA, 17.1 % for CE, and
25.4 % for SVO [19]. Large-sized lesions and cortical in-
volvement were significantly more present in late PSSi
(p = 0.001 and p = 0.002, respectively) compared to those
in early PSSi. However, secondary hemorrhagic trans-
formation frequencies of these lesions were not signifi-
cantly different between the two groups. Vascular
territory distribution of lesion was concentrated in the
middle cerebral artery (MCA) territory in both groups
(47.9 % vs. 69.7 %). Patients with mild functional disabil-
ity were more common in early PSSi group than those
in the late PSSi group (33.3 % vs 15.8 %). However, there
was no statistical significance in vascular distribution or
functional disability. Clinical seizure types (partial, gen-
eralized, or status epilepticus) were not significantly dif-
ferent between the two PSSi groups. The prevalence of
lesion relevant EEG findings were 60.0 % (27/45) in early
PSSi and 73.2 % (52/71) in late PSSi. EEG findings were
not available for three early PSSi patients without seizure
recurrence and five late PSSi patients (two of them had
seizure recurrence). The seizure recurrence rate was
35.4 % (17/48) after early seizure and 48.7 % (37/76)
after late seizure.
Each patient's AED treatment regimen (Table 2) was
decided by the treating neurologist. In the early seizure
group, 14.6 % (7/48) patients were not prescribed AED
after their first seizure. However, AED was started later
in three of these patients due to second unprovoked
seizure. Among early PSSi patients administered with
AEDs, 11 patients had no subsequent seizure even after
AED discontinuation whereas 11 patients had the sec-
ond seizure despite of continuous AED taking. In the
late PSSi group, 9.2 % (7/76) patients were not pre-
scribed AED after the first seizure, and all of them had
the second unprovoked seizure. Among the 22 AED dis-
continued patients in the late PSSi group, 14 developed
second seizure later while the remaining 8 patients did
not have second seizure.
Single vs. recurrent seizures among early post-ischemic
stroke seizure patients
Seizure recurrence related clinical factors in the early
PSSi group were investigated, and results are shown
in Table 3. Males were more common in the recur-
rent seizure group compared to females (70.6 % vs.
54.8 %, p = 0.033 in multivariable analysis). History of
diabetes mellitus and hypertension were more com-
mon in the single seizure group compared to those in
the recurrent seizure group. Atrial fibrillation was
more prevalent in recurrent seizure group compared
to that in the single seizure group (29.4 % vs. 9.7 %).
Cortical involvement was more common in the recur-
rent seizure group (82.4 % vs. 67.7 %), whereas
hemorrhagic transformation was more common in
the single seizure group (19.4 % vs. 11.8 %). Severely
disabled patients were more prevalent in patient with
later seizure recurrence (64.7 % vs. 48.4 %). Partial
seizure type was more common in the recurrent seiz-
ure group (54.7 % vs. 45.2 %).
Single vs. recurrent seizures among late post-ischemic
stroke seizure patients
Seizure recurrence related clinical factors in the late PSSi
group are summarized in Table 4. Young age and male
gender were significantly correlated with higher seizure
recurrence rate in both univariable and multivariable
analyses (p = 0.050 and p = 0.027, respectively). Among
lesion related radiologic findings, large lesion size was
slightly more prevalent in the recurrent seizure group
compared to that in the single seizure group (81.1 % vs.
74.4 %). Patients with later seizure recurrence exhibited
more tendency to have partial seizure (45.9 % vs. 35.9 %)
but less tendency to have status epilepticus (16.2 % vs.
35.9 %) and lesion relevant EEG abnormalities (59.5 %
vs. 76.9 %) than those with single seizure.
Scoring models for predicting seizure recurrence
The validities of scoring models for seizure recur-
rence risk measure are summarized in Table 5 and
Fig. 2. Score 1 included all the above-mentioned 10
clinical predictors, whereas score 2 was concentrated
on lesion related factors after excluding demographic
(sex and age) and comorbid factors (atrial fibrillation).
Score 3 and score 4 included items more prevalent in
seizure recurrence groups (p < 0.3 in multivariable
analysis) of early and late PSSi, respectively. These
models exhibited the best performance with highest
area under the curve (AUC) of 0.735 in early PSSi
and 0.734 in late PSSi. By substituting disability cat-
egorical variables with raw mRS data (Score O − 2
Table 2 Antiepileptic drug regimen of post-ischemic stroke seizures patients
Early onset PSSi (N = 48) Late onset PSSi (N = 76)
AED prescription None Discontinued Continues None Discontinued Continues
(N = 7) (N = 14) (N = 27) (N = 7) (N = 22) (N = 47)
Not recurred 4 11 16 0 8 31
Recurred 3 3 11 7 14 16
AED antiepileptic drug, PSSi post-stroke seizure after ischemic stroke/post-ischemic stroke seizure`
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version), each scale was found to have higher specifi-
city but slightly lower sensitivity than the previous
version (Score O − 1 version). Overall, the validity of
seizure recurrence risk score in the early PSSi group
was better than other models when evaluating based
on gender, atrial fibrillation, cortical lesion, functional
disability, and partial seizure type, with sensitivity of
70.6 % and specificity of 71.0 %. In late PSSi group,
score model based on age, gender, lesion size, and
partial seizure type was exhibited best performance,
with sensitivity of 62.2 % and specificity of 81.1 %.
Two prognostic score models (MESS and PoSERS) re-
ported in previous studies were also used to compare
our study subjects [32, 33]. Both MESS and PoSERS
demonstrated better specificities than our own scales
for late PSSi. However, their sensitivities were much
lower than our scales.
Discussion
PSSi is increasingly encountered in clinical practice as
population ages. A tool to identify patients with high risk
of recurrent unprovoked seizures would benefit such pa-
tients. However, such tool is currently unavailable be-
cause previous studies mainly reported the PSS
incidence related factors rather than seizure recurrence
predicting factors without distinction of stroke etiology.
This could be an important process to identify epilepsy
patients in accordance with the newly proposed ILAE
definition in 2014 as being after single seizure with en-
during predisposition to recurrent seizures at a chance
of greater than 60 % [28, 35].
The main findings of our study are as follows: (1) the
overall prevalence of PSSi among ischemic stroke survi-
vors was 3.3 % (124/3792); (2) seizure recurred patients
among early PSSi (35.4 %, 17/48) exhibited similar ten-
dency to the late PSSi group rather than the general
early PSSi group in some clinical characteristics - atrial
fibrillation, cortical stroke lesion - in addition to the
prevalence of male gender, severe functional disability,
and partial seizure type; (3) seizure recurrence in the late
PSSi group (48.7 %, 37/76) was more common in pa-
tients of younger age (≤65 years old), male gender, large
lesion size, and partial seizure type; (4) the validity of
seizure recurrence risk score with these clinical variables
was improved with sensitivity of 70.6 % and specificity of
71.0 % for the early PSSi group, and with sensitivity of
62.2 % and specificity of 81.1 % for the late PSSi group,
respectively.
It has been reported that seizure onset latency from
antecedent is one of the major AED prescription criteria
of acquired epilepsy based on the investigated risk differ-
ence of subsequent event up to 80 % [9, 11, 14].
Table 3 Clinical characteristics related to seizure recurrence after early onset post-ischemic stroke seizure
Clinical characteristics Not recurred Recurred Univariable analysis Multivariable analysis
(N = 31) (N = 17) p-value OR (95 % CI) p-value OR (95 % CI)
Age (years old) 65.7 ± 14.9 66.1 ± 12.6 0.941 0.882a 0.880 (0.161–4.799)
Male gender 17 (54.8 %) 12 (70.6 %) 0.286 1.976 (0.560–6.971) 0.033* 11.822 (1.222–114.347)
Diabetes mellitus 16 (51.6 %) 4 (23.5 %) 0.059 0.288 (0.077–1.084) 0.347 0.346 (0.038–3.167)
Hypertension 23 (74.2 %) 10 (58.8 %) 0.272 0.497 (0.141–1.747) 0.355 0.353 (0.039–3.206)
Atrial fibrillation 3 (9.7 %) 5 (29.4 %) 0.112 3.889 (0.799–18.938) 0.106 10.451 (0.609–179.306)
Lesion size
Small 4 (12.9 %) 3 (17.6 %) 0.360
Moderate 13 (41.9 %) 4 (23.5 %) 0.576 2.779 (0.077–99.920)
Large 14 (45.2 %) 10 (58.8 %) 0.468 0.440 0.412 (0.043–3.910)
Cortical involvement 21 (67.7 %) 14 (82.4 %) 0.330 2.222 (0.518–9.537) 0.163 6.406 (0.471–87.078)
Hemorrhagic transformation 6 (19.4 %) 2 (11.8 %) 0.694 0.556 (0.099–3.114) 0.197 0.155 (0.009–2.632)
Functional disability
Mild 12 (38.7 %) 4 (23.5 %) 0.402
Moderate 4 (12.9 %) 2 (11.8 %) 0.564 0.386 (0.015–9.788)
Severe 15 (48.4 %) 11 (64.7 %) 0.532 0.293 3.517 (0.349–32.620)
Status epilepticus 8 (25.8 %) 5 (29.4 %) 1.000 1.198 (0.321–4.473) 0.941 1.077 (0.151–7.673)
Relevant EEG findings (N = 45) 17 (54.8 %) 10 (58.8 %) 0.900 0.924 (0.271–3.156) 0.951 1.067 (0.134–8.512)
Partial seizure type 14 (45.2 %) 11 (64.7 %) 0.195 2.226 (0.657–7.545) 0.159 4.619 (0.546–38.873)
OR odds ratio, CI confidence interval, EEG electroencephalography
Statistical significance with p < 0.05*
a Variables were substituted whether patients were younger than 65 years old
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Table 5 Validity tests for post-ischemic stroke seizure recurrence risk score models
Version Itemsa AUC 95 % CI Criteria Sensitivity Specificity + LR - LR
Early Score 1-1 Y, M, A, B, C, H, D, E, F, P 0.653 0.502–0.784 6 58.8 % 67.7 % 1.82 0.61
PSSi Score 1-2 Y, M, A, B, C, H, mRS, E, F, P 0.650 0499–0.782 9 52.9 % 80.7 % 2.74 0.58
Score 2-1 B, C, H, D, E, F, P 0.621 0.470–0.757 5 64.7 % 71.0 % 2.23 0.50
Score 2-2 B, C, H, mRS, E, F, P 0.622 0.471–0.758 8 52.9 % 80.7 % 2.74 0.58
Score 3-1 M, A, C, D, P 0.735 0.588–0.852 3 70.6 % 71.0 % 2.43 0.41
Score 3-2 M, A, C, mRS, P 0.676 0.525–0.803 6 47.1 % 80.7 % 2.43 0.66
MESS mRS≥ 1, abnormal EEG 0.509 0.361–0.657 1 70.6 % 35.5 % 1.09 0.83
PoSERS Supratentorial (X 2), C, H, mRS≥ 3 0.576 0.425–0.717 3 58.8 % 58.1 % 1.40 0.71
Late Score 1-1 Y, M, A, B, C, H, D, E, F, P 0.566 0.447–0.679 7 46.0 % 61.5 % 1.19 0.88
PSSi Score 1-2 Y, M, A, B, C, H, mRS, E, F, P 0.558 0.439–0.671 9 40.5 % 69.2 % 1.32 0.86
Score 2-1 B, C, H, D, E, F, P 0.534 0.416–0.649 5 43.2 % 59.0 % 1.05 0.96
Score 2-2 B, C, H, mRS, E, F, P 0.526 0.408–0.642 7 54.1 % 59.0 % 1.32 0.78
Score 4 Y, M, B, P 0.734 0.620–0.829 3 62.2 % 81.1 % 3.46 0.46
MESS mRS≥ 1, abnormal EEG 0.594 0.475–0.705 1 32.4 % 87.2 % 2.53 0.78
PoSERS Supratentorial (X 2), C, H, mRS≥ 3 0.532 0.414–0.647 4 21.6 % 89.7 % 2.11 0.87
AUC area under the curve, CI confidence interval, +LR positive likely-hood ratio, -LR negative likely-hood ratio, mRS modified Rankin Score, MESS MRC Multicenter
trial for Early Epilepsy and Single Seizure, PoSERS Post-Stroke Epilepsy Risk Scale, EEG electroencephalography
a Y, younger age - below 65 years old (1); M, male (1); A, atrial fibrillation (1); B, bigger lesion size - small (0), moderate (1), large (2); C, cortical involvement (1); H,
hemorrhagic transformation (1); D, functional disability - mild (0), moderate (1), severe (2); E, status epilepticus (1); F, relevant focal EEG finding (1); P, partial
seizure (1)
Table 4 Clinical characteristics related to seizure recurrence after late onset of post-ischemic stroke seizure
Clinical characteristics Not recurred Recurred Univariable analysis Multivariable analysis
(N = 39) (N = 37) p-value OR (95 % CI) p-value OR (95 % CI)
Age (years old) 70.7 ± 9.1 62.7 ± 11.9 0.001** 0.050*a 3.746 (1.000–14.040)
Male gender 14 (35.9 %) 26 (70.3 %) 0.003** 4.221 (1.613–11.043) 0.027* 4.552 (1.183–17.511)
Diabetes mellitus 14 (35.9 %) 10 (27.0 %) 0.406 0.661 (0.249–1.757) 0.460 0.578 (0.135–2.476)
Hypertension 31 (79.5 %) 25 (67.6 %) 0.238 0.538 (0.190–1.518) 0.451 0.566 (0.129–2.488)
Atrial fibrillation 16 (41.0 %) 12 (32.4 %) 0.438 0.690 (0.270–1.764) 0.521 0.647 (0.171–2.443)
Lesion size
Small 2 (5.1 %) 1 (2.7 %) 0.581
Moderate 8 (20.5 %) 6 (16.2 %) 0.999 -
Large 29 (74.4 %) 30 (81.1 %) 0.520 0.298 0.329 (0.041–2.667)
Cortical involvement 37 (94.9 %) 34 (91.9 %) 0.671 0.613 (0.096–3.891) 0.999 -
Hemorrhagic transformation 7 (17.9 %) 13 (35.1 %) 0.089 2.476 (0.858–7.150) 0.688 1.370 (0.296–6.347)
Functional disability
Mild 5 (12.8 %) 7 (18.9 %) 0.802
Moderate 15 (38.5 %) 14 (37.8 %) 0.854 1.216 (0.151–9.796)
Severe 19 (48.7 %) 16 (43.2 %) 0.490 0.558 1.833 (0.205–16.406)
Status epilepticus 14 (35.9 %) 6 (16.2 %) 0.051* 0.346 (0.116–1.030) 0.057 0.208 (0.041–1.048)
Relevant EEG findings (N = 71) 30 (76.9 %) 22 (59.5 %) 0.051* 0.338 (0.111–1.030) 0.118 0.294 (0.063–1.367)
Partial seizure type 14 (35.9 %) 17 (45.9 %) 0.373 1.518 (0.605–3.808) 0.237 2.227 (0.590–8.404)
OR odd ratio, CI confidence interval, EEG electroencephalography
Statistical significance with p < 0.05* and p < 0.01**
a Variables were substituted whether patients were younger than 65 years
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Therefore, early and late PSSi groups were compared
in this study. Different prognostic factors including
seizure recurrence rate are regarded as a reflection of
underlying pathomechanism associated with the en-
during predisposition. Early seizures are thought to
result from acute disruption of brain integrity, meta-
bolic homeostasis, and excitatory glutamate release,
leading to secondary neuronal injury and electrically
irritable tissue. In contrast, late seizures are related to
neuronal circuit reorganization by aberrant gliosis and
development of hyperexcitable cicatrix, eventually
resulting in spontaneous seizures [23, 36]. We hy-
pothesized that clinical characteristics of PSSi patients
might reflect the epileptogenic predisposition of post-
stroke brain. Our results suggested that different epi-
lepsy pathogenesis might be involved in early and late
PSSi because the adjusted ORs of recurrence related
factors did not match each other.
In our study, significantly different predisposing fac-
tors between early and late PSSi groups were: atrial fib-
rillation history, large lesion size, and cortical
involvement of lesion. Seizure recurrence rate between
the two groups did not reach statistical significance pos-
sibly due to the relatively lower recurrence rate in the
late onset PSSi group compared with other large center
studies (12.4–57.1 %) [3, 4, 6, 8]. The ascertained item
lists not only contained plausible factors for acquired
localization-related epilepsy, but also contained implaus-
ible demographic factors (age, sex) and comorbid factors
(e.g. atrial fibrillation). Although establishing causality
based on a statistical association is hazardous, excluding
the latter factors from the suggested score system failed
to enhance the sensitivity or specificity of seizure recur-
rence risk prediction. Considering lower volume of cor-
tical gray matter and decreased excitability due to
degenerative changes, it is easy to assume that younger
patients might develop seizures more often [37]. As for
gender, hormone effect especially progesterone can ac-
count for difference in promoting and enhancing repair
after traumatic brain injury and stroke [38]. The associ-
ation between seizure and cardioembolism is often men-
tioned in published studies [8, 39]. However, such
association remains controversial due to various study
designs and diagnostic testing. Another considering
point is confounders and interaction between predictors,
such as age with seizure manifestation, survival rate,
atrial fibrillation with cortical involvement, and so on.
Among those relatively more plausible epileptogenic
lesion-related factors, cortical location was consistently
found to be an associated factor for the determination of
the probability of seizure. Thus, cortical location can be
an important clinical factor to decide for AED treatment
in clinical practice. The interaction effect between pre-
dictors, especially with lesion size or severe functional
Fig. 2 Receiver operating characteristic curves for the seizure
recurrence risk score models. a Validation in the early onset
post-ischemic stroke seizure (PSSi) group, and b validation in the
late onset PSSi group. Score 1-1 included all 10 items, whereas
score 2-1 excluded age, sex, and atrial fibrillation factors. Score
3-1 (male sex, atrial fibrillation, cortical involvement, functional
disability, and partial seizure) in early onset and score 4 (younger
age at seizure onset, male sex, large stroke lesion, and partial
seizure) in late onset patients (solid line) were composed of
more prevalent items (p < 0.3) in each recurrent group that
showed the largest area under the curve (AUC) among each
group’s suggested scores. Predictive scores from MRC Multicenter
trial for Early Epilepsy and Single Seizures (MESS) and Post-Stroke
Epilepsy Risk Scale (PoSERS) study were applied to compare our
patients. However, they demonstrated little efficacy for detecting
or discriminating seizure recurrence in patients with early and
late onset PSSi
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disability, should be further evaluated with large number
of patients to validate and enhance the specificity of sug-
gested scale. Other factors exhibited discrepancies be-
tween our results and those from previous studies,
possibly due to our specific focus on seizure recurrence
and etiology limitation to ischemic stroke. Extravasation
and irritation of blood metabolism product might have
epileptogenic role in acute phase of stroke [40]. How-
ever, our study result suggest a low correlation between
hemorrhagic transformation of ischemia and seizure re-
currence. Clinical partial seizure type exhibited signifi-
cant positive trend of seizure recurrence in our study,
whereas EEG finding was insignificant. EEG finding of
post-stroke brain especially in acute phase has relatively
low diagnostic value for seizure [41], as it reflects acute
dysfunction of post-stroke brain rather than epilepto-
genic activity. The correlation between status epilepticus
and seizure recurrence was strong in patients with early
PSSi. This might be associated with severe and large
stroke lesion in those patients presenting status epilepti-
cus as early seizures [34].
Although clinicians always deliberately weigh the
pros and cons of AED administration in each individ-
ual, inconsistent rules might result in inappropriate
treatment. In our subjects, there were untreated AED
required for 3 early and 7 late PSSi patients and over-
estimated AED taken by 11 early and 8 late PSSi pa-
tients. Consistent application of evidenced guideline
based on seizure recurrence risk measure with high
specificity could decrease gratuitous side effects and
interactions of AED with many other drugs taken by
disabled elderly patient. The higher predictive power
of our own score than scores of other previous stud-
ies without distinction of stroke etiology indicates the
necessity of distinct score exclusively for ischemic
stroke etiology.
Our study have several limitations. First, we
reviewed the patients’ medical records retrospectively,
so seizure events could have been missed or under-
diagnosed in some patients. Second, the observational
nature of our study nature is prone to uncontrolled
AED prescription, variable follow up duration, or bias
of unmeasured factors. Lastly, the small number of
patients in this study might have limited to derive ad-
justed ORs with multiple predictor variables. How-
ever, we tested the distribution of all continuous
variables and confirmed that they are normally dis-
tributed. Although we selected clinical variables using
a modest statistical guideline of p < 0.3, we found that
the validity of our scoring systems was improved with
relatively good sensitivity and specificity. This kind of
clinical scoring system for seizure recurrence in PSSi
patients could be useful with further validation in the
future large scale prospective study.
Conclusion
Currently, AED treatment protocol for PSSi patients,
especially those with early seizure onset, is dependent
on variable and indefinite reference of each clinician.
The proposed score confined to ischemic stroke sur-
vivors may help clinicians not only in AED treatment
decision, but also in patient selection for further pro-
spective randomized trials, preferably after supple-
ment of case number and external validation to
establish generalizability.
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